Incannex Healthcare IXHL
NASDAQ IXHL
$3.35 -0.02 (-0.59%)
As of: Sep 9, 2026 · 1:52 PM EDT

Incannex Healthcare (IXHL) Intangibles (2022 - 2023)

Incannex Healthcare's (IXHL) quarterly Intangibles came in at $52.7 million in Q2 2023, little changed quarter-over-quarter from $52.7 million in Q4 2022.

Analysis

Incannex Healthcare (IXHL) Intangibles (2022 - 2023) Analysis & Trends

Incannex Healthcare has disclosed Intangibles across 2 years of filings, most recently posting $52.7 million for Q2 2023.

  • In Q2 2023, Intangibles changed N/A year-over-year to $52.7 million; the TTM figure through Jun 2023 stood at $52.7 million (changed N/A YoY), while the FY2023 annual figure was $52.7 million, changed N/A from the prior year.
  • Intangibles came in at $52.7 million for Q2 2023 at Incannex Healthcare, roughly flat from $52.7 million in the prior quarter.
  • In the past five years, Intangibles ranged from a high of $52.7 million in Q4 2022 to a low of $52.7 million in Q4 2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Intangibles (Qtr)
1 Johnson & Johnson 646.53 Bn 625.77 Bn 17.26 Bn 48.23 Bn
2 AbbVie 442.27 Bn 435.70 Bn 12.70 Bn 49.14 Bn
3 Merck 366.81 Bn 359.67 Bn 12.21 Bn 24.98 Bn
4 Novartis Ag 266.82 Bn 259.13 Bn 11.24 Bn 42.07 Bn
5 Pfizer 159.37 Bn 147.67 Bn 10.94 Bn 47.05 Bn
6 Sanofi 52.46 Bn 45.08 Bn 10.79 Bn 30.64 Bn
7 Revolution Medicines 44.12 Bn 44.12 Bn - 63.28 Mn
8 Incyte 25.49 Bn 20.95 Bn 1.57 Bn 103.20 Mn
9 United Therapeutics 21.55 Bn 18.89 Bn 683.80 Mn -
10 Incannex Healthcare 41.37 Mn 41.37 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2023 52.72 Mn
Dec 31, 2022 52.72 Mn